Susquehanna Fundamental Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-54,093	Closed	-$5.03M	–	1750
2021 Q4	$5.03M	Buy	54,093 +18,144	+50%	+$1.2M	0.13%	198
2021 Q3	$2.14M	Buy	35,949 +18,981	+112%	+$1.12M	0.04%	573
2021 Q2	$1.16M	Buy	16,968 +8,970	+112%	+$585K	0.02%	797
2021 Q1	$555K	Sell	7,998 -32,229	-80%	-$2.48M	0.01%	1118
2020 Q4	$3.09M	Buy	+40,227	New	+$3.02M	0.06%	482

Susquehanna Fundamental Investments's ARNA Position: Q1 2022 in Review

Susquehanna Fundamental Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 54,093 shares — an estimated $5.03M sold.

Susquehanna Fundamental Investments first reported a position in ARNA in Q4 2020 and held it in 5 quarters. The position peaked at $5.03M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Susquehanna Fundamental Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Susquehanna Fundamental Investments sold 54,093 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.03M.
Susquehanna Fundamental Investments first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
Susquehanna Fundamental Investments's Arena Pharmaceuticals Inc position peaked at $5.03M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.